ZADITEN

Zaditen Adverse Events Reported to the FDA Over Time

How are Zaditen adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zaditen, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zaditen is flagged as the suspect drug causing the adverse event.

Most Common Zaditen Adverse Events Reported to the FDA

What are the most common Zaditen adverse events reported to the FDA?

Convulsion	73 (4.18%)
Pyrexia	53 (3.04%)
Somnolence	46 (2.64%)
Loss Of Consciousness	31 (1.78%)
Aspartate Aminotransferase Increase...	30 (1.72%)
Alanine Aminotransferase Increased	28 (1.6%)
Agitation	24 (1.38%)
Diarrhoea	23 (1.32%)
Epilepsy	22 (1.26%)
Blood Alkaline Phosphatase Increase...	21 (1.2%)
Liver Disorder	20 (1.15%)
	Show More
Blood Lactate Dehydrogenase Increas...	19 (1.09%)
Overdose	19 (1.09%)
Erythema Multiforme	17 (.97%)
Erythema	16 (.92%)
Febrile Convulsion	16 (.92%)
Pruritus	16 (.92%)
Accidental Overdose	14 (.8%)
Dizziness	14 (.8%)
Haematuria	14 (.8%)
Irritability	14 (.8%)
Malaise	14 (.8%)
Speech Disorder	14 (.8%)
Areflexia	13 (.74%)
Blood Creatine Phosphokinase Increa...	13 (.74%)
Depressed Level Of Consciousness	13 (.74%)
Drug Exposure During Pregnancy	13 (.74%)
Gamma-glutamyltransferase Increased	13 (.74%)
Growth Retardation	13 (.74%)
Pneumonia	13 (.74%)
Toxic Encephalopathy	13 (.74%)
Cough	12 (.69%)
Urticaria	12 (.69%)
Crying	11 (.63%)
Drug Dispensing Error	11 (.63%)
Blood Glucose Increased	10 (.57%)
Mental Retardation	10 (.57%)
Pruritus Generalised	10 (.57%)
Dermatitis Exfoliative	9 (.52%)
Electrocardiogram Qt Prolonged	9 (.52%)
Face Oedema	9 (.52%)
Fall	9 (.52%)
Nasopharyngitis	9 (.52%)
Oedema Peripheral	9 (.52%)
Platelet Count Decreased	9 (.52%)
Syncope	9 (.52%)
Tremor	9 (.52%)
Blister	8 (.46%)
Coarctation Of The Aorta	8 (.46%)
Cystitis	8 (.46%)
Fatigue	8 (.46%)
Feeling Abnormal	8 (.46%)
Gastrointestinal Malformation	8 (.46%)
Headache	8 (.46%)
Oesophageal Atresia	8 (.46%)
Skin Exfoliation	8 (.46%)
Vomiting	8 (.46%)
Abnormal Behaviour	7 (.4%)
Amnesia	7 (.4%)
Condition Aggravated	7 (.4%)
Drug Ineffective	7 (.4%)
Epistaxis	7 (.4%)
Eye Pain	7 (.4%)
Heart Disease Congenital	7 (.4%)
Hepatic Function Abnormal	7 (.4%)
Pallor	7 (.4%)
Pollakiuria	7 (.4%)
Rash	7 (.4%)
Abdominal Pain Upper	6 (.34%)
Agranulocytosis	6 (.34%)
Arthralgia	6 (.34%)
Asthenia	6 (.34%)
Asthma	6 (.34%)
Blood Bilirubin Increased	6 (.34%)
Blood Cholesterol Increased	6 (.34%)
Blood Creatinine Decreased	6 (.34%)
Blood Lactate Dehydrogenase Decreas...	6 (.34%)
Blood Pressure Decreased	6 (.34%)
C-reactive Protein Increased	6 (.34%)
Cheilitis	6 (.34%)
Cyanosis	6 (.34%)
Cystitis Haemorrhagic	6 (.34%)
Disturbance In Attention	6 (.34%)
Eye Irritation	6 (.34%)
Feeling Hot	6 (.34%)
Generalised Erythema	6 (.34%)
Hallucination, Visual	6 (.34%)
Hepatic Enzyme Increased	6 (.34%)
Hyperhidrosis	6 (.34%)
Lymphocyte Count Decreased	6 (.34%)
Nausea	6 (.34%)
Neutrophil Count Increased	6 (.34%)
Ocular Hyperaemia	6 (.34%)
Palpitations	6 (.34%)
Petechiae	6 (.34%)
Salivary Hypersecretion	6 (.34%)
Skin Irritation	6 (.34%)
Staphylococcal Infection	6 (.34%)
Thrombocytopenia	6 (.34%)
Abdominal Pain	5 (.29%)
Blood Pressure Increased	5 (.29%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Zaditen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zaditen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zaditen

What are the most common Zaditen adverse events reported to the FDA?

Neurological	173 (9.91%)
Epidermal And Dermal Conditions	135 (7.74%)
Seizures	126 (7.22%)
Hepatobiliary	88 (5.04%)
Enzyme	63 (3.61%)
Medication Errors	56 (3.21%)
Body Temperature Conditions	53 (3.04%)
Hematology Investigations	48 (2.75%)
Hepatic And Hepatobiliary	42 (2.41%)
Infections - Pathogen Unspecified	36 (2.06%)
Urinary Tract Signs	35 (2.01%)
	Show More
Respiratory	34 (1.95%)
Gastrointestinal Signs	31 (1.78%)
Anxiety Disorders	30 (1.72%)
Cardiac And Vascular Investigations	30 (1.72%)
Gastrointestinal Motility And Defec...	29 (1.66%)
Ocular Infections, Irritations And ...	29 (1.66%)
Mental Impairment	26 (1.49%)
Cardiac And Vascular Disorders Cong...	20 (1.15%)
Renal And Urinary Tract Investigati...	19 (1.09%)
Musculoskeletal And Connective Tiss...	18 (1.03%)
Upper Respiratory Tract Disorders	18 (1.03%)
Eye	17 (.97%)
Chemical Injury And Poisoning	16 (.92%)
Gastrointestinal Tract Disorders Co...	16 (.92%)
Encephalopathies	15 (.86%)
Movement Disorders	15 (.86%)
Angiedema And Urticaria	14 (.8%)
Ocular Neuromuscular	13 (.74%)
Oral Soft Tissue Conditions	13 (.74%)
Skin Vascular Abnormalities	13 (.74%)
Cardiac Disorder Signs	12 (.69%)
Injuries	12 (.69%)
Vascular	12 (.69%)
Salivary Gland Conditions	11 (.63%)
Sleep Disorders	11 (.63%)
Bacterial Infectious	10 (.57%)
Cardiac Arrhythmias	10 (.57%)
Metabolic, Nutritional And Blood Ga...	10 (.57%)
Toxicology And Therapeutic Drug Mon...	10 (.57%)
Vision	10 (.57%)
Allergic Conditions	9 (.52%)
Headaches	9 (.52%)
Muscle	9 (.52%)
Protein And Chemistry Analyses	9 (.52%)
Renal Disorders	9 (.52%)
Viral Infectious	9 (.52%)
White Blood Cell	9 (.52%)
Joint	8 (.46%)
Mood Disorders	8 (.46%)
Neurological, Special Senses And Ps...	8 (.46%)
Platelet	8 (.46%)
Bronchial Disorders	7 (.4%)
Disturbances In Thinking	7 (.4%)
Psychiatric And Behavioural Symptom...	7 (.4%)
Therapeutic And Nontherapeutic Effe...	7 (.4%)
Bladder And Bladder Neck Disorders	6 (.34%)
Lipid Analyses	6 (.34%)
Neuromuscular	6 (.34%)
Ocular Sensory Symptoms	6 (.34%)
Skin Appendage Conditions	6 (.34%)
Ocular Hemorrhages And Vascular	5 (.29%)
Appetite And General Nutritional	4 (.23%)
Changes In Physical Activity	4 (.23%)
Decreased And Nonspecific Blood Pre...	4 (.23%)
Gastrointestinal Therapeutic Proced...	4 (.23%)
Lower Respiratory Tract Disorders	4 (.23%)
Microbiology And Serology	4 (.23%)
Musculoskeletal And Soft Tissue Inv...	4 (.23%)
Somatoform And Factitious	4 (.23%)
Bone Disorders	3 (.17%)
Gastrointestinal Hemorrhages	3 (.17%)
Glucose Metabolism Disorders	3 (.17%)
Immunology And Allergy	3 (.17%)
Myocardial	3 (.17%)
Physical Examination Topics	3 (.17%)
Procedural And Device Related Injur...	3 (.17%)
Therapeutic Procedures And Supporti...	3 (.17%)
Tongue Conditions	3 (.17%)
Chromosomal Abnormalities And Abnor...	2 (.11%)
Cornification And Dystrophic Skin	2 (.11%)
Dental And Gingival Conditions	2 (.11%)
Depressed Mood Disorders	2 (.11%)
Electrolyte And Fluid Balance Condi...	2 (.11%)
External Ear Disorders	2 (.11%)
Fatal Outcomes	2 (.11%)
Fetal Complications	2 (.11%)
Gastrointestinal Conditions	2 (.11%)
Gastrointestinal Inflammatory Condi...	2 (.11%)
Lifestyle Issues	2 (.11%)
Mycoplasmal Infectious	2 (.11%)
Neonatal And Perinatal Conditions	2 (.11%)
Spleen, Lymphatic And Reticulendoth...	2 (.11%)
Suicidal And Self-injurious Behavio...	2 (.11%)
Urolithiases	2 (.11%)
Abortions And Stillbirth	1 (.06%)
Administration Site Reactions	1 (.06%)
Anemias Nonhemolytic And Marrow Dep...	1 (.06%)
Congenital And Hereditary	1 (.06%)
Deliria	1 (.06%)
Gastrointestinal	1 (.06%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zaditen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zaditen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.